Targeted therapy use following Medicare's coverage expansion for next-generation sequencing in older adults with lung cancer.

Published 10/21/2026

Research record: Targeted therapy use following Medicare's coverage expansion for next-generation sequencing in older adults with lung cancer.

Published in JNCI Cancer Spectr; first publication date 2026-10-21. PMID 42902792.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-21

Updated

2026-10-24

Disclaimer

professional use

References

Explore more

More from this section

A Validated Multi-Analyte Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Therapeutic Drug Monitoring and Targeted Toxicological Assessment of 54 Drugs and Metabolites in Human Serum.

More from this section

[Identification and interfering factors of falsely elevated androgen levels in clinical laboratory testing in women].

More from this section

Diagnostic accuracy of a multiplex nucleic acid amplification test for detecting gastrointestinal bacterial pathogens: A multicenter clinical study.